Yu‐Sheng Chao
Publications by Year
Research Areas
Peroxisome Proliferator-Activated Receptors, Diabetes Treatment and Management, Neuropeptides and Animal Physiology, Peptidase Inhibition and Analysis, Cholesterol and Lipid Metabolism
Most-Cited Works
- → Simvastatin Has Anti-Inflammatory and Antiatherosclerotic Activities Independent of Plasma Cholesterol Lowering(2001)413 cited
- → Deficiency in Inducible Nitric Oxide Synthase Results in Reduced Atherosclerosis in Apolipoprotein E-Deficient Mice(2000)208 cited
- → Reduction of Atherosclerosis by the Peroxisome Proliferator-activated Receptor α Agonist Fenofibrate in Mice(2002)188 cited
- → Infectious Agents Are Not Necessary for Murine Atherogenesis(2000)176 cited
- → Structure-Based Drug Design and Structural Biology Study of Novel Nonpeptide Inhibitors of Severe Acute Respiratory Syndrome Coronavirus Main Protease(2006)171 cited
- → Novel Dengue Virus-Specific NS2B/NS3 Protease Inhibitor, BP2109, Discovered by a High-Throughput Screening Assay(2010)120 cited
- → Autoradiographic localization of the sites of uptake, cellular transport, and catabolism of low density lipoproteins in the liver of normal and estrogen-treated rats(1981)119 cited
- → Identification of phenanthroindolizines and phenanthroquinolizidines as novel potent anti-coronaviral agents for porcine enteropathogenic coronavirus transmissible gastroenteritis virus and human severe acute respiratory syndrome coronavirus(2010)101 cited
- → Biochemistry, pharmacokinetics, and toxicology of a potent and selective DPP8/9 inhibitor(2009)98 cited
- → Structure-Based Drug Design of a Novel Family of PPARγ Partial Agonists: Virtual Screening, X-ray Crystallography, and in Vitro/in Vivo Biological Activities(2006)98 cited